Your browser doesn't support javascript.
loading
Combining Colonoscopy With Fecal Immunochemical Test Can Improve Current Familial Colorectal Cancer Colonoscopy Surveillance: A Modelling Study.
Van Wifferen, Francine; Greuter, Marjolein J E; van Leerdam, Monique E; Spanier, Marcel B W; Dekker, Evelien; Vasen, Hans F A; Lansdorp-Vogelaar, Iris; Canfell, Karen; Meijer, Gerrit A; Bisseling, Tanya M; Hoogerbrugge, Nicoline; Coupé, Veerle M H.
Afiliação
  • Van Wifferen F; Decision Modeling Center, Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam Public Health, Amsterdam, The Netherlands. Electronic address: f.vanwifferen@amsterdamumc.nl.
  • Greuter MJE; Decision Modeling Center, Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam Public Health, Amsterdam, The Netherlands.
  • van Leerdam ME; Department of Gastrointestinal Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Spanier MBW; Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, The Netherlands.
  • Dekker E; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Vasen HFA; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Lansdorp-Vogelaar I; Department of Public Health, Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands.
  • Canfell K; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, New South Wales, Sydney, Australia.
  • Meijer GA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bisseling TM; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Hoogerbrugge N; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Coupé VMH; Decision Modeling Center, Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam Public Health, Amsterdam, The Netherlands.
Gastroenterology ; 2024 Aug 28.
Article em En | MEDLINE | ID: mdl-39214503
ABSTRACT
BACKGROUND &

AIMS:

The authors assessed whether familial colorectal cancer (FCRC) surveillance in individuals without hereditary CRC can be optimized

METHODS:

The Adenoma and Serrated Pathway to Colorectal Cancer-FCRC model simulates CRC development in individuals with a family history of CRC at 2-fold and 4-fold increased CRC risk compared with the general population. The authors simulated a strategy without surveillance, the current Dutch guideline (5-yearly colonoscopy between ages 45 and 75 years), and the following 3 sets of alternative strategies colonoscopy surveillance, surveillance combining colonoscopy and fecal immunochemical test (FIT), and FIT-based surveillance. Each set included a range of strategies differing in age range and test interval. The optimal strategy was defined as the strategy with highest quality-adjusted life-years (QALYs) satisfying all of the following criteria in the (near-)efficiency area of the cost-effectiveness frontier and compared with current surveillance; noninferior effectiveness; no substantial increase in colonoscopy burden; and not more expensive.

RESULTS:

The optimal strategy was 10-yearly colonoscopy with 2-yearly FIT between colonoscopies from ages 40 to 80 years for both 2-fold and 4-fold increased CRC risk. At 2-fold risk, this strategy prevented 0.8 more CRC deaths, gained 15.8 more QALYs at 731 fewer colonoscopies, and saved €98,000 over the lifetime of 1000 individuals compared with current surveillance. At 4-fold risk, figures were 2.1 more CRC deaths prevented, 37.0 more QALYs gained at 567 fewer colonoscopies, and €127,000 lower costs. Current surveillance was not (near-)efficient.

CONCLUSIONS:

FIT could play an important role in FCRC surveillance. Surveillance with 10-yearly colonoscopy and 2-yearly FIT between colonoscopies from ages 40 to 80 years increased QALYs and reduced colonoscopy burden and costs compared with current FCRC surveillance.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Gastroenterology Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Gastroenterology Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos